On August 16, local time, "stock god" Warren Buffett announced the latest holdings of its subsidiary Berkshire Hathaway. Compared with the first quarter, there was little change. Three stocks were cleared and one new stock was added. Among the stocks that Berkshire has reduced its holdings, there are many biomedical stocks.
The documents show that the company's total market value of holdings is approximately US$293.023 billion, an increase of approximately 8.4% from the US$270.435 billion in the first quarter of 2021.
According to the provisions of the US Securities and Exchange Commission (SEC), fund managers with assets under management of more than 100 million U.S. dollars must publish a document called "Form 13F" within 45 days after the end of each quarter to disclose stocks and bonds. Position.
Specifically, as of the end of the second quarter, Berkshire's top five major stocks have not increased or decreased, and the top ten holdings accounted for 87.51%, and the positions are still very concentrated. The top five major stocks are Apple's 887.1 million shares, with a market value of US$121.5 billion, accounting for 41% of the total disclosed holdings; Bank of America 1.01 billion shares with a market value of US$41.6 billion; American Express 151.6 million shares with a market value of US$25.1 billion; Coca-Cola 400 million Shares with a market value of US$21.6 billion; Kraft Heinz (KHC.US) 325.6 million shares with a market value of US$13.3 billion.
Among the top ten stocks, Berkshire only changed its position in US Bancorp in the second quarter of 2021. It reduced its holdings by nearly 800,000 shares, and its holdings fell to nearly 129 million shares, with a market value of US$7.342 billion, ranking it eighth.
In terms of increasing positions, Berkshire has only increased its holdings of Kroger, RH Common Stock and Aon Insurance (AON.US) in the second quarter of 2021. This is also Berkshire’s continuous In the second quarter, the three companies mentioned above were increased, of which Aon Insurance was the company that Berkshire built a new warehouse in the first quarter of this year.
Medical insurance company Organon became the only new target for Berkshire in the second quarter of this year. Organon was spun off by the pharmaceutical giant Merck and was established on March 11, 2020. It is a science-based global pharmaceutical company that develops and provides a series of biosimilars for women’s health and prescription therapies for well-known brands. Innovative health solutions.
At the same time, Berkshire also reduced its holdings of 8 stocks and liquidated 3 stocks.
The top five stocks sold were Merck, General Motors, Liberty Global Inc. C, Bristol-Myers Squibb and AbbVie. The three stocks of Axalta Coating Systems, Biogen and Freedom Global were liquidated. Among the companies that have been underweight, there have been many biomedical stocks. General Motors was reduced by 7 million shares, a 10% reduction from the previous month, to 60 million shares, with a market value of US$3.55 billion, accounting for 4.1% of the total outstanding shares. This also made General Motors fall out of Buffett’s top ten holdings. .
According to statistics from 13F data platform Whale Wisdom, in terms of the distribution of individual stocks held by Berkshire at the end of the second quarter, information technology still accounted for the largest share of holdings in the second quarter, accounting for nearly 42%, and the second place was finance, which accounted for nearly 32%. , Consumer necessities accounted for nearly 13%, public utilities and communications, medical and health care accounted for more than 3%, non-essential consumer goods accounted for more than 2%.